Latest from Companies

Market close: F&P Healthcare climbing back, Mainfreight hits $60 again

The New Zealand sharemarket finished an eventful week with a small gain.

Qantas cuts transtasman flights as MIQ spots fill up

Australia-bound passengers may also be hit by cancellations as capacity is cut.

Jarden Brief: Vaccine enthusiasm cools off on Wall Street

Jarden's daily update on the latest market moves and shakes.

Continuous Disclosure: Kiwis line up for Airbnb, Fletcher's comeback

Kiwi investors are expected to line up for a slice of Airbnb when it floats on Nasdaq.

Covid party pooper for airlines: How Qantas will celebrate turning 100

The pandemic arrived as some airlines were planning milestone flights and events.

Market close: Mainfreight, Xero make strong gains

While the two growth stocks hogged the limelight, the S&P/NZX 50 Index had a flat day.

Synlait completes trifecta with capital raise

Synlait's successful capital raising comes as the company resolves a number of issues.

'A significant step': Major airline resumes flights in New Zealand

Quarantine requirements in NZ and Hong Kong put the brakes on leisure travel.

2degrees' owner reports loss amid Bolivian hassle

A game of two halves.

Kiwi health tech firm poised to leap-frog competitors

Coveted European certification will help elbow past rivals in $200b global market.

Global stock rally slows, but optimism over vaccine remains high

The market has calmed since yesterday's excitement.

Market close: Travel and leisure stocks rise on Covid vaccine news

The New Zealand sharemarket had a wild ride.

Fletcher boss optimistic about Ihumātao solution

"We are waiting to hear back from Labour about the resolution."

NZME lifts earnings guidance, refunds staff, plans dividend

Improved forecast driven by better than expected revenue recovery from Covid crisis.

Union: Air NZ 'using public money to line senior managers' pockets'

Staff say it's another kick while airline says execs crucial in navigating through Covid

Jarden Brief: Winners and losers as markets cheer vaccine news

Jarden's daily update on the latest market moves and shakes.